WO2015095769A1 - Compositions nutritives à faible teneur en lactose et leurs procédés de production - Google Patents
Compositions nutritives à faible teneur en lactose et leurs procédés de production Download PDFInfo
- Publication number
- WO2015095769A1 WO2015095769A1 PCT/US2014/071620 US2014071620W WO2015095769A1 WO 2015095769 A1 WO2015095769 A1 WO 2015095769A1 US 2014071620 W US2014071620 W US 2014071620W WO 2015095769 A1 WO2015095769 A1 WO 2015095769A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nutritional composition
- lactose
- protein
- low lactose
- grams
- Prior art date
Links
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 409
- 239000000203 mixture Substances 0.000 title claims abstract description 398
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 title claims abstract description 371
- 239000008101 lactose Substances 0.000 title claims abstract description 370
- 238000000034 method Methods 0.000 title claims abstract description 85
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 190
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 190
- 108010005774 beta-Galactosidase Proteins 0.000 claims abstract description 88
- 102100026189 Beta-galactosidase Human genes 0.000 claims abstract description 86
- 108010059881 Lactase Proteins 0.000 claims abstract description 86
- 229940116108 lactase Drugs 0.000 claims abstract description 86
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 42
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 38
- 239000011707 mineral Substances 0.000 claims abstract description 38
- 235000018102 proteins Nutrition 0.000 claims description 187
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 53
- 150000003271 galactooligosaccharides Chemical class 0.000 claims description 53
- 239000007788 liquid Substances 0.000 claims description 42
- 239000000843 powder Substances 0.000 claims description 31
- 229930182830 galactose Natural products 0.000 claims description 26
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 23
- 239000008103 glucose Substances 0.000 claims description 23
- 230000008569 process Effects 0.000 claims description 18
- 230000001954 sterilising effect Effects 0.000 claims description 17
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 16
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 16
- 229910052802 copper Inorganic materials 0.000 claims description 16
- 239000010949 copper Substances 0.000 claims description 16
- 229910052725 zinc Inorganic materials 0.000 claims description 16
- 239000011701 zinc Substances 0.000 claims description 16
- 235000013336 milk Nutrition 0.000 claims description 15
- 239000008267 milk Substances 0.000 claims description 15
- 210000004080 milk Anatomy 0.000 claims description 15
- 239000012141 concentrate Substances 0.000 claims description 14
- 235000013861 fat-free Nutrition 0.000 claims description 14
- 238000004659 sterilization and disinfection Methods 0.000 claims description 13
- 108010046377 Whey Proteins Proteins 0.000 claims description 11
- 102000007544 Whey Proteins Human genes 0.000 claims description 11
- 108010082495 Dietary Plant Proteins Proteins 0.000 claims description 10
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 9
- 102000014171 Milk Proteins Human genes 0.000 claims description 9
- 108010011756 Milk Proteins Proteins 0.000 claims description 9
- 239000011575 calcium Substances 0.000 claims description 9
- 229910052791 calcium Inorganic materials 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 9
- 235000021239 milk protein Nutrition 0.000 claims description 9
- 238000004806 packaging method and process Methods 0.000 claims description 9
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 8
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 8
- 238000011065 in-situ storage Methods 0.000 claims description 8
- 108010084695 Pea Proteins Proteins 0.000 claims description 7
- 108010073771 Soybean Proteins Proteins 0.000 claims description 7
- 235000019702 pea protein Nutrition 0.000 claims description 7
- 229940001941 soy protein Drugs 0.000 claims description 7
- 235000021119 whey protein Nutrition 0.000 claims description 7
- 235000020183 skimmed milk Nutrition 0.000 claims description 5
- 239000005862 Whey Substances 0.000 claims description 4
- 238000001694 spray drying Methods 0.000 claims description 4
- 240000007594 Oryza sativa Species 0.000 claims description 3
- 235000007164 Oryza sativa Nutrition 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 235000009508 confectionery Nutrition 0.000 claims description 3
- 235000009566 rice Nutrition 0.000 claims description 3
- 235000008939 whole milk Nutrition 0.000 claims description 3
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 claims description 2
- 235000006008 Brassica napus var napus Nutrition 0.000 claims description 2
- 240000000385 Brassica napus var. napus Species 0.000 claims description 2
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 claims description 2
- 235000004977 Brassica sinapistrum Nutrition 0.000 claims description 2
- 241000195493 Cryptophyta Species 0.000 claims description 2
- 244000061456 Solanum tuberosum Species 0.000 claims description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 2
- 235000021307 Triticum Nutrition 0.000 claims description 2
- 230000000415 inactivating effect Effects 0.000 claims description 2
- 241000209140 Triticum Species 0.000 claims 1
- 235000014633 carbohydrates Nutrition 0.000 description 36
- 235000010755 mineral Nutrition 0.000 description 32
- 235000019197 fats Nutrition 0.000 description 24
- 239000004615 ingredient Substances 0.000 description 20
- 239000000047 product Substances 0.000 description 15
- 239000007787 solid Substances 0.000 description 14
- 235000008504 concentrate Nutrition 0.000 description 12
- 235000000346 sugar Nutrition 0.000 description 10
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 9
- 239000002002 slurry Substances 0.000 description 9
- 239000000796 flavoring agent Substances 0.000 description 8
- 235000019634 flavors Nutrition 0.000 description 8
- 150000008163 sugars Chemical class 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 235000003599 food sweetener Nutrition 0.000 description 6
- 230000007062 hydrolysis Effects 0.000 description 6
- 238000006460 hydrolysis reaction Methods 0.000 description 6
- 239000003765 sweetening agent Substances 0.000 description 6
- 238000013019 agitation Methods 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 230000000873 masking effect Effects 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 235000013618 yogurt Nutrition 0.000 description 5
- 108010076119 Caseins Proteins 0.000 description 4
- 102000011632 Caseins Human genes 0.000 description 4
- 201000010538 Lactose Intolerance Diseases 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- -1 WPC80) Substances 0.000 description 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 description 4
- 229960000511 lactulose Drugs 0.000 description 4
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 229920002498 Beta-glucan Polymers 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 3
- 229930091371 Fructose Natural products 0.000 description 3
- 229920002148 Gellan gum Polymers 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 3
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 3
- 235000019485 Safflower oil Nutrition 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 235000010418 carrageenan Nutrition 0.000 description 3
- 239000000679 carrageenan Substances 0.000 description 3
- 229920001525 carrageenan Polymers 0.000 description 3
- 229940113118 carrageenan Drugs 0.000 description 3
- 239000005018 casein Substances 0.000 description 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 3
- 235000021240 caseins Nutrition 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000012628 flowing agent Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 235000013406 prebiotics Nutrition 0.000 description 3
- 235000005713 safflower oil Nutrition 0.000 description 3
- 239000003813 safflower oil Substances 0.000 description 3
- 235000011888 snacks Nutrition 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 235000015424 sodium Nutrition 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 229920001285 xanthan gum Polymers 0.000 description 3
- 235000010493 xanthan gum Nutrition 0.000 description 3
- 239000000230 xanthan gum Substances 0.000 description 3
- 229940082509 xanthan gum Drugs 0.000 description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 2
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241001138401 Kluyveromyces lactis Species 0.000 description 2
- 240000001046 Lactobacillus acidophilus Species 0.000 description 2
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 2
- 229920000881 Modified starch Polymers 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 235000019486 Sunflower oil Nutrition 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- 235000021342 arachidonic acid Nutrition 0.000 description 2
- 229940114079 arachidonic acid Drugs 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 2
- WQZGKKKJIJFFOK-FPRJBGLDSA-N beta-D-galactose Chemical class OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-FPRJBGLDSA-N 0.000 description 2
- 102000005936 beta-Galactosidase Human genes 0.000 description 2
- 229940004120 bifidobacterium infantis Drugs 0.000 description 2
- 239000000828 canola oil Substances 0.000 description 2
- 235000019519 canola oil Nutrition 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 235000005687 corn oil Nutrition 0.000 description 2
- 239000002285 corn oil Substances 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 230000009969 flowable effect Effects 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 2
- 235000010492 gellan gum Nutrition 0.000 description 2
- 239000000216 gellan gum Substances 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 2
- 235000010449 maltitol Nutrition 0.000 description 2
- 239000000845 maltitol Substances 0.000 description 2
- 229940035436 maltitol Drugs 0.000 description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 2
- 235000021486 meal replacement product Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229960003975 potassium Drugs 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 239000001508 potassium citrate Substances 0.000 description 2
- 229960002635 potassium citrate Drugs 0.000 description 2
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 2
- 235000011082 potassium citrates Nutrition 0.000 description 2
- 235000011962 puddings Nutrition 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 229940108325 retinyl palmitate Drugs 0.000 description 2
- 235000019172 retinyl palmitate Nutrition 0.000 description 2
- 239000011769 retinyl palmitate Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 239000002600 sunflower oil Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 2
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N 2,3,4,5-tetrahydroxypentanal Chemical compound OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 1
- PVXPPJIGRGXGCY-TZLCEDOOSA-N 6-O-alpha-D-glucopyranosyl-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)C(O)(CO)O1 PVXPPJIGRGXGCY-TZLCEDOOSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 235000006491 Acacia senegal Nutrition 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 244000247812 Amorphophallus rivieri Species 0.000 description 1
- 235000001206 Amorphophallus rivieri Nutrition 0.000 description 1
- 238000012371 Aseptic Filling Methods 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 235000019743 Choline chloride Nutrition 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 239000001692 EU approved anti-caking agent Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 229920002752 Konjac Polymers 0.000 description 1
- 235000000072 L-ascorbyl-6-palmitate Nutrition 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 244000134552 Plantago ovata Species 0.000 description 1
- 235000003421 Plantago ovata Nutrition 0.000 description 1
- 229920001100 Polydextrose Polymers 0.000 description 1
- 239000009223 Psyllium Substances 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 229920000294 Resistant starch Polymers 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 101100238326 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) SPO21 gene Proteins 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 239000008122 artificial sweetener Substances 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 235000015173 baked goods and baking mixes Nutrition 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 235000021324 borage oil Nutrition 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000015496 breakfast cereal Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 108010033929 calcium caseinate Proteins 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960003178 choline chloride Drugs 0.000 description 1
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 235000020965 cold beverage Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 235000021183 entrée Nutrition 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 125000001976 hemiacetal group Chemical group 0.000 description 1
- 235000019534 high fructose corn syrup Nutrition 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 235000012171 hot beverage Nutrition 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 238000010952 in-situ formation Methods 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000000905 isomalt Substances 0.000 description 1
- 235000010439 isomalt Nutrition 0.000 description 1
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- BJHIKXHVCXFQLS-PQLUHFTBSA-N keto-D-tagatose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-PQLUHFTBSA-N 0.000 description 1
- 239000000252 konjac Substances 0.000 description 1
- 235000010485 konjac Nutrition 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 229940057917 medium chain triglycerides Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 238000010910 nasogastric intubation Methods 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000019895 oat fiber Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000013588 oral product Substances 0.000 description 1
- 229940023486 oral product Drugs 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 235000013856 polydextrose Nutrition 0.000 description 1
- 239000001259 polydextrose Substances 0.000 description 1
- 229940035035 polydextrose Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 229940070687 psyllium Drugs 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229940108461 rennet Drugs 0.000 description 1
- 108010058314 rennet Proteins 0.000 description 1
- 235000021254 resistant starch Nutrition 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 229940080237 sodium caseinate Drugs 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 235000019976 tricalcium silicate Nutrition 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
- A23C9/203—Dietetic milk products not covered by groups A23C9/12 - A23C9/18 containing bifidus-active substances, e.g. lactulose; containing oligosaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/1203—Addition of, or treatment with, enzymes or microorganisms other than lactobacteriaceae
- A23C9/1206—Lactose hydrolysing enzymes, e.g. lactase, beta-galactosidase
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
- A23L5/25—Removal of unwanted matter, e.g. deodorisation or detoxification using enzymes
Definitions
- the present disclosure relates to low lactose nutritional compositions and methods of producing low lactose nutritional compositions. More particularly, the present disclosure relates to methods of producing a low lactose nutritional composition utilizing at least one high lactose source of protein.
- Certain nutritional compositions are formulated to be suitable for consumption by individuals who are lactose intolerant.
- Formulations of such nutritional compositions with low levels of lactose present certain disadvantages, including the expense associated with low lactose protein sources as compared to protein sources that have a high lactose content (e.g. , more than 15% by weight of the protein source is lactose).
- Low lactose nutritional compositions and methods of producing low lactose nutritional compositions are provided.
- the exemplary methods described herein include producing an initial nutritional composition comprising protein, carbohydrate, fat, and minerals, and from 30- 100% by weight of the total protein is provided by at least one high lactose protein source. Lactase is added to the initial nutritional composition to digest the lactose in the initial nutritional composition to form a low lactose nutritional composition.
- the low lactose nutritional composition comprises galactooligosaccharides (GOS) formed in situ from the hydrolysis of lactose by the added lactase.
- GOS galactooligosaccharides
- a method of producing a packaged low lactose nutritional composition having lactose in an amount of no more than 2000 milligrams per liter and from 1.2- 12.7 grams of galactooligosaccharides (GOS) per liter is provided.
- the method includes producing an initial nutritional composition comprising protein, carbohydrate, fat, and minerals, and from 30-100% by weight of the total protein is provided by at least one high lactose protein source.
- the initial nutritional composition comprises from 20-100 grams of protein per liter and optionally contains GOS, and the minerals comprise from 5-30 milligrams of zinc per liter and from 0.8-3 milligrams of copper per liter.
- Lactase is added to the initial nutritional composition to digest the lactose in the initial nutritional composition, thereby forming a low lactose nutritional composition.
- the low lactose nutritional composition is packaged to form the packaged low lactose nutritional composition.
- the packaged low lactose nutritional composition comprises lactose in an amount of no more than 2000 milligrams per liter, GOS in an amount of 1.2-12.7 grams per liter, glucose in an amount of 10-55 grams per liter, and galactose in an amount of 5-40 grams per liter.
- a low lactose nutritional composition comprises from 5-20 grams of total protein per serving, and 30- 100% by weight of the total protein is provided by at least one high lactose protein source.
- the low lactose nutritional composition comprises from 20-55 grams of carbohydrate per serving.
- the carbohydrate comprises GOS, glucose, and galactose, and other added carbohydrates (e.g., fructose and sucrose), and 0.5-15%) by weight of the carbohydrate is provided by GOS.
- the low lactose nutritional composition also comprises from 5-15 grams of fat per serving, and minerals selected from the group consisting of zinc, copper, free calcium, and combinations thereof.
- the low lactose nutritional composition comprises from 100-200 milligrams of lactase per serving.
- the low lactose nutritional composition comprises lactose in an amount of no more than 500 milligrams per serving, and at least a portion of the GOS is formed in situ in the low lactose nutritional composition.
- a low lactose nutritional composition prepared by a specified process comprises producing an initial nutritional composition comprising protein, carbohydrate, fat, and minerals. A portion of the total protein (e.g., from 30- 100% by weight) is provided by at least one high lactose protein source. The initial nutritional composition comprises from 20-100 grams of protein per liter. Additionally, the initial nutritional composition is substantially free of galactose and optionally contains GOS. Lactase is added to the initial nutritional composition to digest the lactose in the initial nutritional composition to form the low lactose nutritional composition.
- the low lactose nutritional composition comprises lactose in an amount of no more than 2000 milligrams per liter, GOS in an amount of 1.2-12.7 grams per liter, glucose in an amount of 10-55 grams per liter, and galactose in an amount of 5-40 grams per liter.
- Low lactose nutritional compositions and methods of producing low lactose nutritional compositions are provided.
- the exemplary methods and low lactose nutritional compositions described herein feature one or more high lactose protein sources typically not utilized to formulate nutritional compositions suitable for consumption by individuals who are lactose intolerant.
- utilization of high lactose protein sources reduces the cost of producing a low lactose nutritional composition because high lactose protein sources are generally significantly cheaper than lactose-free or low lactose protein sources.
- the exemplary methods described herein result in the in situ production of a significant amount of galactooligosaccharides (GOS) in the low lactose nutritional composition, which exhibit beneficial prebiotic activity when consumed.
- GOS galactooligosaccharides
- low lactose nutritional composition refers to a nutritional composition having lactose in an amount of no more than 2000 milligrams per liter, or in certain embodiments no more than 500 milligrams per serving ⁇ e.g., 8 fl. oz.).
- the low lactose nutritional composition includes protein, carbohydrate, fat, and minerals. At least 30% by weight of the total protein in the low lactose nutritional composition is provided by at least one high lactose protein source.
- the low lactose nutritional composition may be formulated in various product forms including, but not limited to, liquids, solids, powders, semi-solids, semi-liquids, nutritional supplements, and any other nutritional product form known in the art.
- a nutritional composition in powder form may often be reconstituted to form a nutritional composition in liquid form.
- the low lactose nutritional compositions disclosed herein are generally suitable for oral consumption by a human.
- high lactose protein source refers to a protein source in powder form that comprises at least 15% by weight of lactose.
- high lactose protein source may refer to a protein source in liquid form that contains at least 4% by weight of lactose. It should be understood that the amount of lactose contained in the high lactose protein source refers to the amount of lactose in the high lactose protein source prior to the addition of any lactase as described herein.
- low lactose protein source refers to a mammalian milk-based protein source in powder form that comprises less than 4% by weight of lactose.
- lactase refers to a ⁇ -galactosidase enzyme, which catalyzes the hydrolysis of ⁇ -D-galactosides (e.g. , lactose) into their component sugars by hydrolysis of the terminal non-reducing ⁇ -D-galactose residues.
- ⁇ -D-galactosides e.g. , lactose
- lactase may be active lactase or inactivated lactase.
- packaged low lactose nutritional composition refers to a low lactose nutritional composition that is contained within a hermetically sealed container.
- the packaged low lactose nutritional composition is a nutritional liquid, while in certain other embodiments the packaged low lactose nutritional composition is a solid, such as a nutritional powder.
- the nutritional liquid may also be formulated as a suspension, an emulsion, a solution, and so forth.
- Some semi-solid examples include puddings, yogurts, gels, gelatins, and doughs.
- the presently disclosed low lactose nutritional compositions and methods of producing the same are based on the unexpected discovery that an initial nutritional composition comprising protein with at least 30% by weight of the total protein provided by at least one high lactose protein source, carbohydrate, fat, and minerals can be transformed into a low lactose nutritional composition utilizing lactase.
- This discovery is particularly surprising since the current state of the art indicates that the presence of certain minerals, such as copper, zinc, and soluble calcium, as well as fat, can inhibit lactase activity.
- the methods described herein result in the in situ formation of significant amounts of GOS in the low lactose nutritional compositions.
- the low lactose nutritional compositions include GOS, a highly sought after nutritional ingredient that exhibits prebiotic activity, without the costs associated with purchasing, storing, or handling an actual GOS commodity ingredient.
- a method of producing a packaged low lactose nutritional composition having lactose in an amount of no more than 2000 milligrams per liter and from 1.2- 12.7 grams of GOS per liter is provided.
- the method includes producing an initial nutritional composition comprising protein, carbohydrate, fat, and minerals, and from 30-100% by weight of the total protein is provided by at least one high lactose protein source.
- the initial nutritional composition comprises from 20-100 grams of protein per liter and optionally contains GOS, and the minerals comprise from 5-30 milligrams of zinc per liter and from 0.8-3 milligrams of copper per liter.
- the total amount of protein provided by the at least one high lactose protein source will be 6-20 grams per liter (assuming 20 grams of total protein per liter) to 30-100 grams per liter (assuming 100 grams of total protein per liter.
- Lactase is added to the initial nutritional composition to digest the lactose in the initial nutritional composition, thereby forming a low lactose nutritional composition.
- the low lactose nutritional composition is packaged to form the packaged low lactose nutritional composition.
- the packaged low lactose nutritional composition comprises lactose in an amount of no more than 2000 milligrams per liter, GOS in an amount of 1.2-12.7 grams per liter, glucose in an amount of 10-55 grams per liter, and galactose in an amount of 5-40 grams per liter.
- a low lactose nutritional composition comprises from 5-20 grams of protein per serving, and 30-100% by weight of the total protein is provided by at least one high lactose protein source. It should be understood that the total amount of protein provided by the at least one high lactose protein source will be 1.5-20 grams of protein per serving of the low lactose nutritional composition.
- the low lactose nutritional composition comprises from 20-55 grams of carbohydrate per serving.
- the carbohydrate comprises GOS, glucose, galactose, and other added carbohydrates (e.g., fructose and sucrose), and 0.5-15%) by weight of the carbohydrate is provided by GOS.
- the low lactose nutritional composition also comprises from 5-15 grams of fat per serving, and minerals selected from the group consisting of zinc, copper, free calcium, and combinations thereof. Furthermore, the low lactose nutritional composition comprises from 100-200 milligrams (or 1,900-15,000 GU of Biolactase LTM from Kerry Ingredients & Flavours) of lactase per serving. The low lactose nutritional composition comprises lactose in an amount of no more than 500 milligrams per serving, and at least a portion of the GOS is formed in situ in the low lactose nutritional composition. [0022] In a third embodiment, a low lactose nutritional composition prepared by a specified process is provided.
- the process comprises producing an initial nutritional composition comprising protein, carbohydrate, fat, and minerals.
- a portion of the total protein (e.g., from 30- 100% by weight) in the initial nutritional composition is provided by at least one high lactose protein source.
- the initial nutritional composition comprises from 20-100 grams of protein per liter, is substantially free of galactose, and optionally contains GOS.
- GOS galactose
- the total amount of protein provided by the at least one high lactose protein source will be 6-20 grams per liter (assuming 20 grams of total protein per liter) to 30-100 grams per liter (assuming 100 grams of total protein per liter.
- Lactase is added to the initial nutritional composition to digest the lactose in the initial nutritional composition to form the low lactose nutritional composition.
- the low lactose nutritional composition comprises lactose in an amount of no more than 2000 milligrams per liter, GOS in an amount of 1.2-12.7 grams per liter, glucose in an amount of 10-55 grams per liter, and galactose in an amount of 5-40 grams per liter.
- the low lactose compositions according to the first, second, and third exemplary embodiments include protein, carbohydrate, fat, and minerals.
- the low lactose nutritional composition includes from 5-20 grams of total protein per serving of the low lactose nutritional composition.
- the low lactose nutritional composition includes about 5 grams to about 20 grams, about 5 grams to about 15 grams, about 5 grams to about 10 grams, or about 10 grams to about 20 grams of total protein per serving of the low lactose nutritional composition.
- the low lactose nutritional composition comprises from 20-100 grams of total protein per liter of the low lactose nutritional composition.
- the low lactose nutritional composition includes about 20 grams to about 100 grams, about 20 grams to about 90 grams, about 20 grams to about 75 grams, about 20 grams to about 50 grams, about 20 grams to about 30 grams, or about 90 grams to about 100 grams of total protein per liter of the low lactose nutritional composition.
- from 30-100% by weight of the total protein is provided by at least one high lactose protein source.
- from 30-80% by weight of the total protein is provided by at least one high lactose protein source.
- the high lactose protein source include non-fat dry milk, skim milk powder, whole milk powder, certain whey protein concentrates (e.g., WPC34, WPC50), certain milk protein concentrates (e.g., MPC42, MPC56, MPC70), sweet whey, acid whey, concentrated skim milk, and combinations thereof.
- 30-80% by weight of the total protein is provided by one or more high lactose protein sources, 0-40%> by weight of the total protein is provided by one or more vegetable protein sources, and 0-30%> by weight of the total protein is provided by one or more low lactose protein sources.
- Suitable vegetable protein sources for use in the methods and compositions described herein include intact, hydrolyzed, and partially hydrolyzed vegetable protein sources including, but not limited to, pea proteins, soy proteins, rice proteins, potato proteins, algae proteins, wheat proteins, canola proteins, and combinations thereof.
- suitable low lactose protein sources include, but are not limited to, milk protein isolates, whey protein isolates, certain milk protein concentrates (e.g., MPC80), certain whey protein concentrates (e.g., WPC80), casein (including rennet casein and acid casein), casemates (including calcium caseinate and sodium caseinate), fish, mycoprotein, collagen, and combinations thereof.
- MPC80 and WPC34 refers to the protein source (MPC refers to milk protein concentrate; WPC refers to whey protein concentrate) and the protein source's approximate amount of protein, by weight percent (MPC80 refers to a milk protein concentrate that is about 80%, by weight, protein; WPC34 refers to a whey protein concentrate that is about 34%, by weight, protein).
- MPC80 refers to milk protein concentrate that is about 80%, by weight, protein
- WPC34 refers to a whey protein concentrate that is about 34%, by weight, protein
- the protein in the low lactose nutritional composition is provided entirely by at least one high lactose protein source. In certain embodiments of the first, second, and third embodiments, the protein in the low lactose nutritional composition is provided entirely by non-fat dry milk. In certain exemplary embodiments according to the first, second, and third embodiments, about 80%> by weight of the total protein is provided by non-fat dry milk and about 20% by weight of the total protein is provided by milk protein concentrate (e.g., MPC80 or other low lactose protein source).
- milk protein concentrate e.g., MPC80 or other low lactose protein source
- about 70% of the total protein is provided by non-fat dry milk, about 15% of the total protein is provided by soy protein, and about 15% of the total protein is provided by pea protein.
- about 55% of the total protein is provided by non-fat dry milk, about 15% of the total protein is provided by milk protein concentrate (i.e., a low lactose protein source), about 15%) of the total protein is provided by soy protein, and about 15% of the total protein is provided by pea protein.
- about 60% of the total protein is provided by non-fat dry milk, about 10% of the total protein is provided by milk protein concentrate (i.e., a low lactose protein source), about 15%) of the total protein is provided by soy protein, and about 15% of the total protein is provided by pea protein.
- milk protein concentrate i.e., a low lactose protein source
- soy protein a low lactose protein source
- pea protein a protein systems
- the particular percentages of protein sources discussed above are based on the amount of protein in the low lactose nutritional composition that is provided by a particular source. For example, consider a low lactose nutritional composition that contains a total of 9 grams of protein in a serving. If the total protein is provided by three sources, those sources being about 70% from non-fat dry milk, about 15% from soy protein, and about 15% from pea protein, then about 6.3 grams of protein will be provided by the non-fat dry milk, and about 1.35 grams of protein will be provided by each of the soy protein and the pea protein. It should also be understood that in many instances the protein sources are not pure protein. For example, non-fat dry milk typically comprises about 36%, by weight, protein. Accordingly, if the composition includes about 6.3 grams of protein from non-fat dry milk, then the composition would include a total of about 17.5 grams of non-fat dry milk as a protein source.
- the low lactose nutritional composition comprises at least one source of carbohydrate in addition to the glucose, galactose, and GOS created from the digestion of the lactose.
- the at least one source of carbohydrate suitable for use in certain embodiments of the low lactose nutritional compositions disclosed herein may be simple, complex, or variations or combinations thereof. Generally, any source of carbohydrate may be used so long as it is suitable for use in oral nutritional compositions and is otherwise compatible with any other selected ingredients or features present in the low lactose nutritional composition.
- Non-limiting examples of carbohydrate sources suitable for use in the low lactose nutritional compositions described herein include maltodextrin, hydrolyzed or modified starch or cornstarch, glucose polymers, corn syrup, corn syrup solids, rice-derived carbohydrates, sucrose, fructose, high fructose corn syrup, honey, sugar alcohols (e.g., maltitol, erythritol, sorbitol), isomaltulose, sucromalt, pullulan, potato starch, and other slowly-digested carbohydrates, dietary fibers including, but not limited to, fructooligosaccharides (FOS), inulin, oat fiber, soy fiber, gum arabic, sodium carboxymethylcellulose, methylcellulose, guar gum, gellan gum, locust bean gum, konjac flour, hydroxypropyl methylcellulose, tragacanth gum, karaya gum, gum acacia, chitosan, arabinoglactins, glucom
- the low lactose nutritional composition comprises from 20-55 grams of carbohydrate per serving of the low lactose nutritional composition.
- the low lactose nutritional composition comprises about 20 grams to about 50 grams, about 20 grams to about 40 grams, about 20 grams to about 35 grams, about 35 grams to about 40 grams, or about 40 grams to about 55 grams of carbohydrate per serving of the low lactose nutritional composition.
- the low lactose nutritional composition comprises from 80-325 grams of carbohydrate per liter of the low lactose nutritional composition.
- the low lactose nutritional composition comprises about 88 grams to about 300 grams, about 100 grams to about 250 grams, or about 165 grams to about 325 grams of carbohydrate per liter of the low lactose nutritional composition.
- the carbohydrate comprises GOS, glucose, and galactose, and 0.5-15% by weight of the carbohydrate is provided by the GOS.
- GOS glucose, and galactose
- 0.5-15% by weight of the carbohydrate is provided by the GOS.
- 0.6- 15% by weight of the carbohydrate is provided by GOS, including 0.75-8%, 1-6%, 1.5-4%, 5- 8%), 6-12%), and also including 8-15% by weight of the carbohydrate is provided by GOS.
- At least a portion of the total amount of GOS present in the low lactose nutritional composition is formed in situ during production of the low lactose nutritional composition.
- about 80-95%) of the GOS present in the low lactose nutritional composition is formed in situ during production of the low lactose nutritional composition.
- the low lactose nutritional composition includes a significant amount of GOS that is not provided by a stand-alone source of GOS.
- the low lactose nutritional composition includes about 1.2 grams to about 12 grams, about 1.5 grams to about 10 grams, about 2 grams to about 8 grams, about 2 grams to 6 grams, or about 8 grams to about 12 grams of GOS per liter of the low lactose nutritional composition.
- the low lactose nutritional composition comprises glucose in an amount of 10-55 grams per liter, and galactose in an amount of 5-40 grams per liter.
- the low lactose nutritional composition includes about 10 grams to about 40 grams, about 15 grams to about 35 grams, or about 30 grams to about 50 grams of glucose per liter of the low lactose nutritional composition.
- the low lactose nutritional composition includes about 5 grams to about 35 grams, about 15 grams to about 25 grams, or about 30 grams to about 40 grams of galactose per liter of the low lactose nutritional composition.
- the units of milligrams per liter applies to the liquid form of the composition.
- the concentration of components or ingredients in the composition are discussed in terms of milligrams per liter (or grams per liter)
- this should be understood to refer to the final concentration of the component or ingredient when the composition is reconstituted to a liquid (e.g., after addition of water or other aqueous solvent) and ready for consumption.
- the low lactose nutritional composition comprises 15-75 grams of reducing sugars per liter.
- the low lactose nutritional composition includes about 15 grams to about 50 grams, about 15 grams to about 30 grams, about 15 grams to about 20 grams, or about 50 grams to about 75 grams of reducing sugars per liter of the low lactose nutritional composition.
- a "reducing sugar” as used herein refers to sugars that include an aldehyde group or a hemiacetal group. For example, both glucose and galactose are reducing sugars.
- the amount of reducing sugars is lowered by the formation of GOS, which utilizes a portion of the glucose and galactose monomers formed as a result of the lactose hydrolysis.
- GOS utilizes a portion of the glucose and galactose monomers formed as a result of the lactose hydrolysis.
- This reduction in reducing sugars via the formation of GOS is particularly advantageous in that reducing sugars are well known for their involvement in Maillard browning, which can produce off- flavors and can affect the color of the resulting nutritional composition.
- the low lactose nutritional compositions of the first, second, and third embodiments comprise at least one source of fat.
- the low lactose nutritional composition comprises from 5-15 grams of fat per serving.
- the low lactose nutritional composition includes about 5 grams to about 10 grams, about 5 grams to about 8 grams, or about 8 grams to about 15 grams per serving.
- the low lactose nutritional composition comprises from 20-50 grams of fat per liter of the low lactose nutritional composition.
- the low lactose nutritional composition includes about 20 grams to about 40 grams, about 20 grams to about 30 grams, or about 40 grams to about 50 grams of fat per liter of the low lactose nutritional composition.
- any source, or combination of sources, of fat may be used so long as it is suitable for use in oral nutritional compositions.
- the source of fat may be derived from plants, animals, and combinations thereof.
- suitable sources of fat for use in the low lactose nutritional compositions described herein include coconut oil, fractionated coconut oil, soy oil, corn oil, olive oil, safflower oil, high oleic safflower oil, high gamma- linolenic acid (GLA) safflower oil, MCT oil (medium chain triglycerides), sunflower oil, high oleic sunflower oil, palm oil, palm kernel oil, palm olein, canola oil, marine oil, cottonseed oil, arachidonic acid, eicosapentaenoic acid, docosahexaenoic acid, gamma-linolenic acid, conjugated linolenic acid from any source, borage oil, and combinations thereof.
- embodiments of the low lactose nutritional composition according to the first, second, and third embodiments disclosed herein comprise one or more minerals.
- the low lactose nutritional composition may comprise minerals including, but not limited to, zinc, copper, free calcium, and combinations thereof.
- the low lactose nutritional composition comprises from 5-30 milligrams of zinc per liter and from 0.8-3 milligrams of copper per liter.
- the low lactose nutritional composition includes about 5 milligrams to about 20 milligrams, about 5 milligrams to about 15 milligrams, or about 20 milligrams to about 30 milligrams of zinc per liter of the low lactose nutritional composition. In certain embodiments of the first, second, and third embodiments, the low lactose nutritional composition includes about 0.8 milligrams to about 2.5 milligrams, about 0.8 milligrams to about 1.75 milligrams, about 0.8 milligrams to about 1.25 milligrams, or about 2.5 milligrams to about 3 milligrams of copper per liter of the low lactose nutritional composition.
- certain embodiments of the low lactose nutritional composition may include other minerals, non-limiting examples of which include calcium, selenium, potassium, iodine, phosphorus, magnesium, iron, manganese, sodium, molybdenum, chromium, chloride, and combinations thereof.
- lactase is added to an initial nutritional composition that has a high lactose content (e.g., more than 2000 milligrams of lactose per liter), and that also includes minerals such as zinc, copper, and free calcium.
- These particular minerals are known to adversely affect the ability of lactase to sufficiently hydrolyze lactose. Accordingly, the final level of lactose achieved by adding lactase to an initial nutritional composition containing these minerals was particularly unexpected.
- the low lactose nutritional compositions according to the second embodiment and certain embodiments of the first and third embodiment comprise from 100-200 milligrams of lactase per serving of the low lactose nutritional composition (or about 1 ,900 to about 15,000 GU of Biolactase LTM from Kerry Ingredients & Flavours).
- the lactase may be active lactase or inactivated lactase (e.g., inactivated by heat treatment of the nutritional composition).
- the lactase catalyzes the hydrolysis of lactose present in the high lactose protein source.
- the lactase digests the lactose to a level that is acceptable for consumption by individuals who are lactose intolerant.
- the low lactose nutritional composition includes lactose in an amount of no more than 2000 milligrams per liter of the low lactose nutritional composition.
- the low lactose nutritional composition includes about 10 milligrams to about 2000 milligrams, about 100 milligrams to about 1500 milligrams, or about 500 milligrams to about 1000 milligrams of lactose per liter.
- the low lactose nutritional composition includes lactose in an amount of no more than 500 milligrams per liter of the low lactose nutritional composition.
- the low lactose nutritional composition comprises lactose in an amount of no more than 500 milligrams per serving of the low lactose nutritional composition.
- the amount of lactose per serving will vary with the particular serving size of the low lactose nutritional composition, but will not exceed an amount of 2000 milligrams per liter.
- the low lactose nutritional composition comprises no more than 725 milligrams of lactulose per serving. In certain embodiments according to the first, second, and third embodiments, the low lactose nutritional composition contains no lactulose.
- the formation of lactulose is known to form when lactose is subjected to heat, such as during heat sterilization processes.
- Lactulose is a nondigestible sugar that is known to cause gastrointestinal discomfort, and is often used in the treatment of chronic constipation.
- the low lactose nutritional compositions according to the methods and compositions disclosed herein include those suitable for oral administration.
- Oral administration includes any form of administration in which the low lactose nutritional composition passes through the esophagus of the individual.
- oral administration includes nasogastric intubation, in which a tube is run from through the nose to the stomach of the individual to administer food.
- the low lactose nutritional composition is formulated as, and intended for consumption in, any known or otherwise suitable oral product form.
- Any solid, liquid, semi-solid, semi-liquid, or powder product form, including combinations or variations thereof, are suitable for use herein, provided that such forms allow for safe and effective oral consumption of the ingredients as also defined herein.
- the low lactose nutritional composition is a solid nutritional product.
- solid nutritional products include snack and meal replacement products, including those formulated as bars, sticks, cookies or breads or cakes or other baked goods, frozen liquids, candy, breakfast cereals, snack chips or bites, frozen or retorted entrees and so forth.
- the serving may be about 25 grams to about 150 grams.
- the low lactose nutritional composition is a nutritional powder.
- the nutritional powder is in a flowable or scoopable form that can be reconstituted with water or another aqueous liquid prior to consumption.
- the nutritional powders disclosed herein include both spray dried and dry mixed or dry blended powders.
- the serving may be about 40 grams to about 50 grams, reconstituted in an appropriate volume of water or other aqueous liquid.
- the low lactose nutritional composition is a nutritional liquid.
- nutritional liquids include snack and meal replacement products, hot or cold beverages, shakes, and so forth.
- the nutritional liquids are formulated as suspensions or emulsions, but the nutritional liquids can also be formulated in any other suitable forms such as solutions, liquid gels, liquid yogurts, and so forth.
- the serving when the low lactose nutritional composition is a liquid, the serving is within a range of from 30-500 milliliters (about 1 fl. oz. to about 17 fl. oz.). As discussed above, the lactose concentration of the low lactose nutritional composition is generally no more than 2000 milligrams of lactose per liter (or no more than about 60 milligrams of lactose per fl. oz.). In certain other embodiments according to the first, second, and third embodiments, when the low lactose nutritional composition is a liquid, the serving is about 237 milliliters (about 8 fl.
- the serving when the low lactose nutritional composition is a liquid, the serving is from about 177 milliliters to about 417 milliliters (about 6 fl. oz. to about 14 fl. oz.). In yet other embodiments according to the first, second, and third embodiments, when the low lactose nutritional composition is a liquid, the serving is from about 207 milliliters to about 266 milliliters (about 7 fl. oz. to about 9 fl. oz.).
- the serving is from about 30 milliliters to about 120 milliliters (about 1 fl. oz. to about 4 fl. oz.).
- the low lactose nutritional composition may be formulated as semi-solid or semi-liquid compositions (e.g., puddings, gels, yogurts, etc.). In other embodiments of the first, second, and third embodiments, the low lactose nutritional composition may be in the form of tablets (e.g., chewable, coated, etc.), pastes, gels, or yogurts. [0045]
- the low lactose nutritional compositions disclosed herein are useful to provide sole, primary, or supplemental sources of nutrition, as well as providing one or more of the benefits as described herein.
- the low lactose nutritional composition provides up to 1000 kcal of energy per serving, including from 20-900 kcal, from 40-700 kcal, from 50-500 kcal, from 150-475 kcal, from 200-450 kcal, or from 200-400 kcal per serving.
- the low lactose nutritional composition may further comprise optional components or ingredients that may modify the physical, chemical, aesthetic, or processing characteristics of the low lactose nutritional composition or serve as a nutraceutical component.
- optional ingredients are known or otherwise suitable for use in nutritional products and may also be used in the low lactose nutritional compositions disclosed herein, provided that such optional ingredients are safe for oral administration and are compatible with the essential and other ingredients in the selected product form.
- Non-limiting examples of such optional ingredients include preservatives, emulsifying agents, buffers, creatine, fructooligosaccharides, polydextrose, prebiotics, probiotics (e.g., Lactobacillus acidophilus, Bifidobacterium infantis, etc.), vitamins, additional minerals, colorants, flavors, thickening agents and stabilizers, lubricants, and so forth.
- the low lactose nutritional composition may further comprise at least one sweetening agent.
- the at least one sweetening agent is at least one sugar alcohol such as maltitol, erythritol, sorbitol, xylitol, mannitol, isomalt, and lactitol, or at least one artificial or high potency sweetener such as acesulfame K, aspartame, sucralose, saccharin, stevia, tagatose, and combinations thereof.
- the sweetening agents may be useful in nutritional compositions to provide a desirable flavor profile.
- the sweetening agents and combinations thereof are effective in masking undesirable flavors, for example, as sometimes associated with the use of vegetable proteins.
- the low lactose nutritional composition may comprise at least one sweetening agent with a concentration in a range from at least 0.01%, including from about 0.01% to about 5%, and also including from about 0.1 % to about 1%, by weight of the low lactose nutritional composition.
- a flowing agent or anti-caking agent may be included in certain embodiments of the low lactose nutritional composition according to the first, second, and third embodiments disclosed herein to retard clumping or caking of a nutritional powder embodiment over time and to make the nutritional powder flow easily from its container.
- Any flowing or anti-caking agents that are known or otherwise suitable for use in a nutritional powder are suitable for use herein, non-limiting examples of which include tricalcium phosphate, silicates, and combinations thereof.
- concentration of the flowing agent or anti-caking agent in certain embodiments of the low lactose nutritional composition according to the first, second, and third embodiments disclosed herein varies depending upon the product form, the other selected ingredients, the desired flow properties, and so forth, but most typically range from about 0.01% to about 4%, including from about 0.1% to about 2%, by weight of the low lactose nutritional composition.
- the low lactose nutritional composition may comprise a stabilizer.
- Any stabilizer that is known or otherwise suitable for use in a nutritional composition is also suitable for use herein, some non-limiting examples of which include gums such as xanthan gum.
- the stabilizer may represent from about 0.01% to about 5%, including from about 0.5% to about 3%, including from about 0.7% to about 1.5%, by weight of the low lactose nutritional composition.
- the low lactose nutritional composition may further comprise any of a variety of vitamins or related nutrients, non-limiting examples of which include vitamin A, vitamin E, vitamin D2, vitamin D3, vitamin A palmitate, vitamin E acetate, vitamin C palmitate (ascorbyl palmitate), vitamin K, thiamine, riboflavin, pyridoxine, vitamin B12, carotenoids (e.g., beta- carotene, zeaxanthin, lutein, lycopene), niacin, folic acid, pantothenic acid, biotin, vitamin C, choline, inositol, salts and derivatives thereof, and combinations thereof.
- vitamins or related nutrients non-limiting examples of which include vitamin A, vitamin E, vitamin D2, vitamin D3, vitamin A palmitate, vitamin E acetate, vitamin C palmitate (ascorbyl palmitate), vitamin K, thiamine, riboflavin, pyridoxine, vitamin B12, carotenoids (e.g., beta- caro
- the low lactose nutritional compositions optionally include one or more masking agents to reduce or otherwise obscure the development of any residual bitter flavors and after taste in the low lactose nutritional compositions over time.
- Suitable masking agents include natural and artificial sweeteners, sodium sources such as sodium chloride, and hydrocolloids, such as guar gum, xanthan gum, carrageenan, gellan gum, and combinations thereof.
- the amount of masking agent in certain embodiments of the low lactose nutritional composition may vary depending upon the particular masking agent selected, other ingredients in the formulation, and other formulation or product target variables. Such amounts, however, most typically range from 0.01% to 3%), including form 0.15% to 3%, and also including from 0.2%> to 2.5%, by weight of the low lactose nutritional composition.
- the various embodiments of the low lactose nutritional compositions described herein may be advantageously produced in accordance with the methods of the first and third embodiments disclosed herein.
- the methods according to the first and third embodiments disclosed herein comprise producing an initial nutritional composition comprising protein, carbohydrate, fat, and minerals.
- the phrase "initial nutritional composition” as used herein refers to a nutritional composition that has more than 2000 milligrams of lactose per liter, includes from 20-100 grams of protein per liter and has not been treated with lactase.
- the initial nutritional composition includes minerals selected from the group consisting of zinc, copper, free calcium, and combinations thereof.
- the initial nutritional composition includes from 5-30 milligrams of zinc per liter and from 0.8-3 milligrams of copper per liter.
- the initial nutritional composition optionally includes GOS.
- the initial nutritional composition is substantially free of galactose, substantially free of glucose, or substantially free of both galactose and glucose.
- the initial nutritional composition may be considered “substantially free of galactose” if the initial nutritional composition contains less than 0.1%, less than 0.05%, and also including 0% galactose by weight of the initial nutritional composition.
- the initial nutritional composition may be considered “substantially free of glucose” if the initial nutritional composition contains less than 0.1 %, less than 0.05%>, and also including 0%> glucose by weight of the initial nutritional composition.
- the initial nutritional compositions according to the methods disclosed herein utilize a protein system wherein from 30-100% by weight of the total protein is provided by at least one high lactose protein source.
- the protein system is such that about 80% by weight of the total protein is provided by one or more high lactose protein sources.
- the protein system is such that about 50%> by weight of the total protein is provided by one or more high lactose protein sources.
- the high lactose protein source may be selected from any one or more of the previously discussed high lactose protein sources, such as non-fat dry milk, skim milk powder, whole milk powder, whey protein concentrates, and so forth.
- the initial nutritional composition comprises from 20-100 grams of protein per liter.
- the initial nutritional composition includes a protein system consisting entirely of one or more high lactose protein sources
- certain high lactose protein sources inherently include a significant amount of minerals (e.g., sodium, potassium, phosphorus), which could result in compositions having mineral levels beyond recommended dietary limits.
- minerals e.g., sodium, potassium, phosphorus
- more than 30% by weight of the total protein in the initial nutritional composition is provided by one or more high lactose protein sources, but less than 100% by weight of the total protein in the initial nutritional composition is provided by one or more high lactose protein sources.
- the initial nutritional composition includes protein comprising, by weight, 30-80%) from one or more high lactose protein sources, 0-40%> from one or more vegetable protein sources, and 0-30%> from one or more low lactose protein sources.
- protein comprising, by weight, 30-80%) from one or more high lactose protein sources, 0-40%> from one or more vegetable protein sources, and 0-30%> from one or more low lactose protein sources.
- the initial nutritional composition may be prepared by any process or suitable method (now known or known in the future) for making a selected product form. Many such techniques are known for any given product form such as nutritional liquids or nutritional powders and can readily be applied by one of ordinary skill in the art to the various embodiments of the methods disclosed herein.
- a protein-in-fat (PIF) slurry for example, a protein-in-fat (PIF) slurry, a carbohydrate- mineral (CHO-MIN) slurry, and a protein-in-water (PIW) slurry.
- PIF protein-in-fat
- CHO-MIN carbohydrate- mineral
- PIW protein-in-water
- the PIF slurry is formed by heating and mixing an oil (e.g., canola oil, corn oil) and then adding an emulsifier (e.g., lecithin), fat soluble vitamins, and a portion of the total protein (e.g., non-fat dry milk) with continued heat and agitation.
- an oil e.g., canola oil, corn oil
- an emulsifier e.g., lecithin
- fat soluble vitamins e.g., non-fat dry milk
- the CHO-MIN slurry is formed by adding with heated agitation to water: minerals (e.g., potassium citrate, dipotassium phosphate, sodium citrate), trace and ultra trace minerals (TM/UTM premix), and thickening or suspending agents (e.g., avicel, gellan, carrageenan).
- minerals e.g., potassium citrate, dipotassium phosphate, sodium citrate
- trace and ultra trace minerals e.g., avicel, gellan, carrageenan
- thickening or suspending agents e.g., avicel, gellan, carrageenan
- additional minerals e.g., potassium chloride, magnesium carbonate, potassium iodide
- carbohydrates e.g., fructooligosaccharides, sucrose, corn syrup
- the three resulting slurries are blended together with heated agitation and the pH is adjusted to the desired range, e.g., 6.6 to 7, after which the nutritional composition may be subjected to a heat treatment, such as high-temperature short- time (HTST) or ultra high temperature (UHT) processing.
- HTST high-temperature short- time
- UHT ultra high temperature
- the nutritional composition can be heat treated, emulsified, homogenized, and cooled.
- Water soluble vitamins and ascorbic acid may be added (if applicable), the pH may be adjusted (if necessary), flavors are added, and any additional water can be added to adjust the solids content to the desired range.
- lactase is added to the initial nutritional composition to digest (i.e., hydro lyze) the lactose in the initial nutritional composition to thereby form a low lactose nutritional composition.
- the amount of lactase added to the initial nutritional composition ranges from 0.4-2 grams per liter of the initial nutritional composition, including from 0.5-1.75 grams of lactase per liter, from 0.6-1.5 grams of lactase per liter, and also including from 0.75-1.5 grams of lactase per liter.
- the amount of lactase added to the initial nutritional composition is based on the amount of the high lactose protein source present.
- the weight ratio of lactase added to the initial nutritional composition to the high lactose protein source ranges from 1 :400 to 1 : 18. Virtually any lactase may be utilized in the methods disclosed herein.
- lactases examples include Biolactase LTM, produced by fermentation of a selected strain of Kluyveromyces lactis (Kerry Ingredients & Flavours, Cork, Ireland), and Maxilact® LGX 5000, a purified lactase preparation isolated from a strain of the dairy yeast Kluyveromyces marxianus var. lactis (DSM Food Specialties B.V., Delft, The Netherlands).
- the method further comprises subjecting the initial nutritional composition with added lactase to a holding period of 12-24 hours to form the low lactose nutritional composition, including from 14-24 hours, from 16-24 hours, from 18-24 hours, from 20-24 hours, from 12-18 hours, from 12- 16 hours, and also including from 12-14 hours.
- This holding period allows time for the lactase to digest the lactose, particularly when the initial nutritional composition with added lactase is maintained at a reduced temperature ⁇ e.g., 2-7 °C).
- the holding period is carried out in the packaging container.
- the initial nutritional composition is transferred to a packaging container. Lactase is then added to the packaging container, which is then hermetically sealed or otherwise closed. The initial nutritional composition with added lactase in the packaging container is then subjected to the holding period, during which a packaged low lactose nutritional composition is formed.
- the initial nutritional composition with added lactase in the packaging container is maintained at a temperature between 2-7°C during the holding period
- the packaged low lactose nutritional composition may be subjected to a sterilization process, such as retort sterilization.
- the initial nutritional composition with added lactase is maintained at a temperature between 2-7°C during a 12-24 hour holding period to form the low lactose nutritional composition.
- This temperature range is beneficial for limiting microbial growth, particularly where the initial nutritional composition is not sterilized prior to the addition of the lactase.
- the initial nutritional composition with added lactase is held for a period of 1-5 hours at a temperature between 35-40°C to form the low lactose nutritional composition.
- This temperature range is beneficial for increasing the rate of hydrolysis of the lactose and reducing cycle time.
- the methods according to the first and third embodiments may further comprise heating the low lactose nutritional composition, thereby inactivating residual lactase.
- the low lactose nutritional composition is heated to a particular temperature, or temperature range, and is held at the particular temperature, or within the temperature range, for a sufficient amount of time to inactivate residual lactase.
- the method further comprises heating the low lactose nutritional composition to a temperature between 70-85°C and maintaining the low lactose nutritional composition within the temperature range for 5-30 seconds to inactivate residual lactase.
- the method further comprises heating the low lactose nutritional composition to a temperature between 55-65°C and maintaining the low lactose nutritional composition within the temperature range for 25-35 minutes to inactivate residual lactase.
- the initial nutritional composition is sterilized to form a sterilized initial nutritional composition prior to the addition of the lactase.
- any sterilization process known to those of ordinary skill in the art may be utilized for sterilizing the initial nutritional composition.
- Non-limiting examples of such sterilization processes include ultra-high temperature processing and high temperature short time processing.
- the initial nutritional composition is heated to a high temperature (e.g., from 135-145°C) for a short period of time, such as 1-6 seconds.
- a high temperature short time sterilization process the initial nutritional composition is heated to a temperature within a range of about 70-80°C for a time period of about 15-30 seconds.
- the lactase added to the sterilized initial nutritional composition is a sterile lactase so as to avoid potential contamination by addition of the lactase.
- a sterile lactase is added to the sterilized initial nutritional composition by aseptic dosing.
- lactase may be passed through a sufficiently sized mesh (e.g., less than about 0.2 microns) that prevents microorganisms and the like from passing through as the lactase is added to the sterilized initial nutritional composition.
- Suitable aseptic dosing equipment for use in the methods disclosed herein is commercially available and is well known to those of ordinary skill in the art.
- the sterilized initial nutritional composition with the aseptically dosed lactase may be subjected to a holding period of 12-24 hours at a temperature between 20-25°C to ensure that the lactase adequately digests the lactose.
- the sterilized initial nutritional composition with the sterile lactase may be packaged by aseptic filling.
- the container is sterilized (e.g., by hydrogen peroxide treatment) prior to being filled with the nutritional composition.
- the sterilized initial nutritional composition with the sterile lactase will form an aseptic low lactose nutritional composition within the sterilized container. Since the packaged low lactose nutritional composition is already sterile, no additional heat treatment is required. Accordingly, in certain embodiments of the methods disclosed herein, the low lactose nutritional composition includes residual active lactase. However, in other embodiments, the packaged low lactose nutritional composition may be subjected to a heat treatment, as previously described, to inactivate residual lactase.
- the low lactose nutritional composition is sterilized.
- the initial nutritional composition with added lactase may be held for a period of 1- 5 hours at a temperature between 35-40°C to form the low lactose nutritional composition, which may then be subjected to a sterilization process.
- a wide variety of sterilization processes known to those of skill in the art may be utilized to sterilize the low lactose nutritional composition, including the sterilization processes described above.
- the low lactose nutritional composition is packaged and sterilized by techniques such as aseptic, retort, or hot-fill sterilization. Such sterilization techniques are well known to those of ordinary skill in the art.
- the low lactose nutritional composition produced in accordance with the first and third embodiments described herein may be a nutritional powder. Accordingly, in certain embodiments of the methods of the first and third embodiments, after the low lactose nutritional product is formed, the method further comprises spray drying the low lactose nutritional composition to form a powdered low lactose nutritional composition prior to packaging. Virtually any spray drying method may be utilized to produce the powdered low lactose nutritional compositions contemplated herein. After production of the powdered low lactose nutritional compositions, the powder may be appropriately packaged in a sterile container.
- a packaged low lactose nutritional composition having lactose in an amount of no more than 2000 milligrams per liter and from 1.2-12.7 grams of GOS per liter is produced.
- the method includes producing an initial nutritional composition comprising protein, carbohydrate, fat, and minerals.
- the initial nutritional composition comprises more than 2000 milligrams of lactose per liter, from 5-30 milligrams of zinc per liter, from 0.8-3 milligrams of copper per liter, is substantially free of galactose, substantially free of glucose, and optionally contains GOS.
- At least one high lactose protein source is utilized to provide 30-100% by weight of the total protein in the initial nutritional composition.
- Lactase is added to the initial nutritional composition in an amount of 0.4-2 grams per liter to digest the lactose in the initial nutritional composition, thereby forming a low lactose nutritional composition.
- the low lactose nutritional composition is packaged to form the packaged low lactose nutritional composition.
- the packaged low lactose nutritional composition comprises from 20-100 grams of protein per liter, from 80-325 grams of carbohydrate per liter, from 20-50 grams of fat per liter, lactose in an amount of no more than 2000 milligrams per liter, GOS in an amount of 1.2-12.7 grams per liter, glucose in an amount of 10-55 grams per liter, and galactose in an amount of 5-40 grams per liter.
- a packaged low lactose nutritional composition having lactose in an amount of no more than 2000 milligrams per liter and from 1.2-12.7 grams of GOS per liter is produced.
- the method includes producing an initial nutritional composition comprising protein, carbohydrate, fat, and minerals.
- the initial nutritional composition comprises more than 2000 milligrams of lactose per liter, from 5-30 milligrams of zinc per liter, from 0.8-3 milligrams of copper per liter, is substantially free of galactose, and optionally contains GOS.
- the initial nutritional composition includes 30- 80% by weight of total protein from a high lactose protein source, 0-40% by weight of total protein from a vegetable protein, and 0-30% by weight of total protein from a low lactose protein source. Lactase is added to the initial nutritional composition in an amount of 0.4-2 grams per liter to digest the lactose in the initial nutritional composition, thereby forming a low lactose nutritional composition.
- the low lactose nutritional composition is packaged to form the packaged low lactose nutritional composition.
- the packaged low lactose nutritional composition comprises from 20-100 grams per liter of protein, from 80-325 grams of carbohydrate per liter, from 20-50 grams of fat per liter, lactose in an amount of no more than 2000 milligrams per liter, GOS in an amount of 1.2-12.7 grams per liter, glucose in an amount of 10-55 grams per liter, and galactose in an amount of 5-40 grams per liter.
- Examples 1 and 2 illustrate certain exemplary embodiments of a low lactose nutritional composition in powder form according to the first, second, and third embodiments disclosed herein. All ingredient amounts are listed in Table 1 as kilogram per 1000 kilogram batch of product, unless otherwise specified.
- Examples 3 and 4 illustrate certain exemplary embodiments of a low lactose nutritional composition in powder form according to the first, second, and third embodiments disclosed herein. All ingredient amounts are listed in Table 3 as kilogram per 1000 kilogram batch of product, unless otherwise specified.
- Vitamin ADEK Premix 0.177 0.177
- Example 5 illustrates an exemplary embodiment of a low lactose nutritional composition in liquid form according to the first, second, and third embodiments disclosed herein. All ingredient amounts are listed in Table 5 as kilogram per 1000 kilogram batch of product, unless otherwise specified.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Dairy Products (AREA)
Abstract
L'invention concerne des compositions nutritives à faible teneur en lactose et des procédés de production de compositions nutritives à faible teneur en lactose. Les procédés comprennent la production d'une composition nutritive initiale comprenant des protéines, des glucides, des lipides et des minéraux. Au moins une source de protéines à forte teneur en lactose est utilisée pour constituer 30 à 100 % en poids de la teneur totale en protéines de la composition nutritive initiale. De la lactase est ajoutée à la composition nutritive initiale pour digérer le lactose présent dans la composition nutritive initiale afin d'obtenir une composition nutritive à faible teneur en lactose.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361918337P | 2013-12-19 | 2013-12-19 | |
US61/918,337 | 2013-12-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2015095769A1 true WO2015095769A1 (fr) | 2015-06-25 |
Family
ID=52293298
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2014/071620 WO2015095769A1 (fr) | 2013-12-19 | 2014-12-19 | Compositions nutritives à faible teneur en lactose et leurs procédés de production |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2015095769A1 (fr) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10542763B2 (en) | 2016-12-02 | 2020-01-28 | Fairlife, Llc | Non-browning lactose-free milk powder and methods of making same |
WO2021180702A1 (fr) * | 2020-03-10 | 2021-09-16 | Dsm Ip Assets B.V. | Poudre de lait à teneur réduite en lactose |
US11503836B2 (en) | 2020-10-20 | 2022-11-22 | Michael J. McCloskey | Process for making lactose-free milk powders |
WO2023102101A1 (fr) * | 2021-12-01 | 2023-06-08 | The Coca-Cola Company | Procédé de préparation d'un produit laitier sans lactose contenant des galacto-oligosaccharides, et produit laitier associé |
WO2024231340A1 (fr) * | 2023-05-05 | 2024-11-14 | N.V. Nutricia | Composition nutritionnelle avec du galactose pour nourrissons ou jeunes enfants |
EP4548769A1 (fr) * | 2023-11-03 | 2025-05-07 | Vreugdenhil Groep B.V. | Procédé, dispositif et système de fabrication de poudre de lait, et poudre de lait pouvant être obtenue par ledit procédé |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4853246A (en) * | 1987-12-01 | 1989-08-01 | Tetra Pak Inc. | Sweetened high protein milk product and process for producing same |
US20070196439A1 (en) * | 2006-02-13 | 2007-08-23 | Catani Steven J | Lactose-reduced dairy compositions and related methods |
WO2011069224A1 (fr) * | 2009-12-07 | 2011-06-16 | Leonardo Carella | Formule de glace italienne à faible teneur en hydrates de carbone, à haute teneur en protéines et enrichie en fibres, et sa méthode de fabrication |
US20110212222A1 (en) * | 2008-10-23 | 2011-09-01 | Meiji Co., Ltd. | Fermented whey preparation and method for producing the same |
-
2014
- 2014-12-19 WO PCT/US2014/071620 patent/WO2015095769A1/fr active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4853246A (en) * | 1987-12-01 | 1989-08-01 | Tetra Pak Inc. | Sweetened high protein milk product and process for producing same |
US20070196439A1 (en) * | 2006-02-13 | 2007-08-23 | Catani Steven J | Lactose-reduced dairy compositions and related methods |
US20110212222A1 (en) * | 2008-10-23 | 2011-09-01 | Meiji Co., Ltd. | Fermented whey preparation and method for producing the same |
WO2011069224A1 (fr) * | 2009-12-07 | 2011-06-16 | Leonardo Carella | Formule de glace italienne à faible teneur en hydrates de carbone, à haute teneur en protéines et enrichie en fibres, et sa méthode de fabrication |
Non-Patent Citations (1)
Title |
---|
MINTEL GROUP: "GNPD Record-ID 2184606: Nordic Berries Smoothie Meal Replacement Product Description", GNPD ONLINE DATABASE, 1 October 2013 (2013-10-01), pages 1 - 4, XP055171945, Retrieved from the Internet <URL:http://www.gnpd.com/sinatra/recordpage/2184606/> [retrieved on 20150225] * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10542763B2 (en) | 2016-12-02 | 2020-01-28 | Fairlife, Llc | Non-browning lactose-free milk powder and methods of making same |
US11266158B2 (en) | 2016-12-02 | 2022-03-08 | Fairlife, Llc | Non-browning lactose-free milk powder and methods of making same |
WO2021180702A1 (fr) * | 2020-03-10 | 2021-09-16 | Dsm Ip Assets B.V. | Poudre de lait à teneur réduite en lactose |
CN115243550A (zh) * | 2020-03-10 | 2022-10-25 | 帝斯曼知识产权资产管理有限公司 | 乳糖降低的乳制品粉 |
US20240180183A1 (en) * | 2020-03-10 | 2024-06-06 | Dsm Ip Assets B.V. | Lactose reduced dairy powder |
US11503836B2 (en) | 2020-10-20 | 2022-11-22 | Michael J. McCloskey | Process for making lactose-free milk powders |
WO2023102101A1 (fr) * | 2021-12-01 | 2023-06-08 | The Coca-Cola Company | Procédé de préparation d'un produit laitier sans lactose contenant des galacto-oligosaccharides, et produit laitier associé |
WO2024231340A1 (fr) * | 2023-05-05 | 2024-11-14 | N.V. Nutricia | Composition nutritionnelle avec du galactose pour nourrissons ou jeunes enfants |
EP4548769A1 (fr) * | 2023-11-03 | 2025-05-07 | Vreugdenhil Groep B.V. | Procédé, dispositif et système de fabrication de poudre de lait, et poudre de lait pouvant être obtenue par ledit procédé |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20200230162A1 (en) | Nutritional formulations using human milk oligosaccharides for modulating inflammation | |
AU2012260945B2 (en) | Milk oligosaccharide-galactooligosaccharide composition for infant formula containing the soluble oligosaccharide fraction present in milk, and having a low level of monosaccharides, and a process to produce the composition | |
CN103096736B (zh) | 包含hmb钙和可溶蛋白质的基本透明的营养液体 | |
EP2346356B2 (fr) | Composition liquide de protéines à haute teneur en matières grasses | |
WO2015095769A1 (fr) | Compositions nutritives à faible teneur en lactose et leurs procédés de production | |
CN102458151B (zh) | 具有低单价金属离子含量的液体肠营养组合物 | |
JP2017518078A (ja) | ジャガイモを基にしたタンパク質混合物およびジャガイモタンパク質を含む栄養組成物 | |
TW201446154A (zh) | 胺基酸及蛋白質水解產物爲底質之具有穩定乳液系統之配方 | |
AU2017358442B2 (en) | Nutritional compositions providing dietary management of colic | |
US9278110B2 (en) | Anti-regurgitation and/or anti-gastrooesophageal reflux composition, preparation and uses | |
WO2015105981A2 (fr) | Essentialité conditionnelle de hmb | |
EP2745705A1 (fr) | Usage nutritionnel d'oligosaccharides du lait humain | |
WO2016029074A1 (fr) | Boisson nutritionnelle contenant une protéine de riz | |
US20160029679A1 (en) | Use of specific carbohydrate systems during pregnancy for preventing fat accumulation in pregnant women | |
US20160317600A1 (en) | Nutritional composition comprising hydrolyzed protein | |
WO2017116805A1 (fr) | Produits nutritionnels comprenant de la lutéine | |
JP2019519229A (ja) | 栄養強化され、無菌加工された飲料の安定性及び口当たりの増強 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14824736 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 14824736 Country of ref document: EP Kind code of ref document: A1 |